Emmanuelle Wilhelm

MD, PhD, Postdoctoral research fellow |📍🇪🇸🇧🇪🇱🇺 | passionate about #ParkinsonsDisease #HolisticHealth | @hmhospitales | former @DuqueLab @4womeninscience

[Emmanuelle Wilhelm @evh_wilhelm]

Pinch me please! 👉🏼 1st project in Parkinson’s disease for both me & @DuqueLab just got published in @MDJ_Journal! 🤩 Grateful to my co-authors & all participants 🫶🏼 Honestly, what a crazy PhD journey 🎢🤯🙊
https://t.co/FCU9G2q3eN
#parkinson #TMS #motorcontrol #bradykinesia

[Michael Okun @MichaelOkun]

Airborne particulate matter pollution associated w/ dementia, new @JAMAInternalMed study and guess what the author suggest there may be interventions to reduce pollutants may decrease your lifetime risk. However, folks we need to stop putzing around and start now to save ours and the next generation! @endingpdbook https://t.co/Glaz9xiihC

[Michael Okun @MichaelOkun]

Everyone is excited about the potential for psychedelic treatment of Parkinson's and neurodegenerative diseases. Read this new piece @JAMAPsych which outlines the challenges including the need for the treatment to be available to 'all.'
'Classic psychedelics like psilocybin, lysergic acid diethylamide (LSD), and dimethyltryptamine (DMT) (ayahuasca’s psychoactive ingredient) interact with the serotonin signaling system principally as agonists to the serotonin 5-HT2A receptor Current psychedelics research carries the baggage of past ethical transgressions, including egregious experimentation with LSD on unwitting study “participants” including individuals with disabilities and those who were incarcerated in the 1950s. It places a unique burden on researchers to be transparent in their aims and methods and to establish a firm grounding of trust with study participants. Because of that dark history, people from racial and ethnic minoritized groups may be particularly hesitant to participate in research. Yet inclusion of diverse study populations is necessary to ensure that findings are applicable across individuals with varying demographic characteristics. Also, since patients are particularly vulnerable during a psychedelic experience due to altered perceptions, an increased posture of openness, and potential for the clinician to be imbued by the patient with medical and spiritual authority, the clinical staff’s role needs to be structured in ways that prevent possible abuses.'
https://t.co/LFRTHdpuad

[Emmanuelle Wilhelm @evh_wilhelm]

Also, very grateful for the beautiful collaboration with @UZLeuven thanks to @DrABoogers and Bart Nuttin! 🙏🤗

[Emmanuelle Wilhelm @evh_wilhelm]

Feel free to check out our latest preprint on the study of corticospinal dynamics underlying action preparation in PD patients treated with bilateral STN-DBS! 🤓 As always, very interested in possible comments and questions! 🧐🤗 @DuqueLab @GDerosiere @insilicobiology 🙏🙏

[medRxiv @medrxivpreprint]

Subthalamic deep brain stimulation alleviates motor symptoms without restoring deficits in corticospinal suppression during movement preparation in Parkinson disease https://t.co/29iCbo5NpJ #medRxiv

[Emmanuelle Wilhelm @evh_wilhelm]

@Andrew_Akbashev @MauraMonesca

[Emmanuelle Wilhelm @evh_wilhelm]

Tomorrow, Doctor @AnnaLatorre14 will visit us at @UCLouvain_be. Join us in person, if you are around, or let me know if you would be interested in having the link to join her talk online! 🤓 @DuqueLab
#movementdisorders #neuromodulation #TMS

[Emmanuelle Wilhelm @evh_wilhelm]

If you’re around, you’re invited to join this talk by Prof. @ignacio_obeso at @UCLouvain_be this Friday! 🤓

[Andreas Horn @andreashorn_]

Excited to see my entire newsfeed celebrating this. I think this could turn out to become the historical „NeuroImage event“ that changed publishing in the Neuro community. @ElsevierConnect @WileyNeuro @SpringerNature take note!

[Michael Okun @MichaelOkun]

PD folks your voices matter. EPA pledges action on TCE! "The collective evidence association between TCE exposure+#Parkinsons accumulating. Many research groups examining the association and we anticipate more information will be available soon." https://t.co/N4GgS82ZsB

[Julian Neumann @neumann_wj]

The @ICNeuromodulate lab is hiring a medical doctor for @ERC_Research #StG on #reinforcement effects of #deepbrainstimulation in #Parkinson disease at @ChariteBerlin. Come discover how we support instead of disrupt brain circuit activity with #DBS, #ECoG & #MachineLearning.

[Parkinson's UK @ParkinsonsUK]

"I feel passionately about spreading the word to the general public that Parkinson’s isn’t a disease that just affects older people."

Tizzy is 27 and was diagnosed with Parkinson’s at the age of 25 and had originally investigated symptoms when she was 21.

This is her story 👇🏽

[Julian Neumann @neumann_wj]

Moving, fast and slow: Excellent review by Damian Herz and Peter Brown on #Parkinson bradykinesia from the perspective of behavioral modelling and control and utility theory. Is Parkinson's disease bradykinesia the result of changed effort cost computations?

[Michael Okun @MichaelOkun]

"If data on childhood trauma and Parkinson's can be replicated, we must ask why?"
"Reminder: how important obtaining a complete life history can be when strategizing on a plan. Life experiences matter and can impact symptoms." https://t.co/E5zXw6OlHw https://t.co/FreP5rNOVV

[Richelle Flanagan 💚💚💚💚 @RichelleFlan]

12 scientific abstracts will be selected for “Hot Topics” @WorldPDCongress to present your work in front of up to 1,000 people, including many of the leaders in the field.Deadline 13.1.23 https://t.co/9WQwAdgfl4 @basbloem @MichaelOkun @DrISubramanian

[Emmanuelle Wilhelm @evh_wilhelm]

@loic @elonmusk Wow, that would be a huge leap for humanity! 🚀💫

[Brain @Brain1878]

Barber et al. show that patients with REM sleep behaviour disorder with established dopaminergic deficits have blunted pupillary responses to reward. Pupillary reward sensitivity may therefore be a marker of prodromal dopaminergic decline. https://t.co/pELE2S03V3

[Daily Science @dailyscience2]

Un lien établi entre des altérations du contrôle moteur et la maladie de Parkinson https://t.co/j9ZgR8JLNM

[Emmanuelle Wilhelm @evh_wilhelm]

Very grateful to the team of @UCLouvain_be for helping us make our research findings more accessible to non-specialists with these types of articles! 🧠 🙏🏼🤓🫶🏼@GDerosiere @DuqueLab @insilicobiology 👩🏼���⚕️👨🏼‍🔬🧑🏽‍⚕️

[Richelle Flanagan 💚💚💚💚 @RichelleFlan]

Delighted tspeaking about living #parkinsonsdisease @EUneurology event tomorrow. You can still register online & raise your voice for our needs as #womenlivingwithneurologicalconditions. @ParkinsonsEU @FitzgeraldFrncs @naiireland @ParkinsonsIre @womenspdproject @MyMovesMatter

[Indu Subramanian @DrISubramanian]

It's world #movementdisorders day! @movedisorder @PMDAlliance @ParkinsonDotOrg @MichaelJFoxOrg @DavisPhinneyFND @WNGtweets @pdavengers @WorldPDCongress Shout out to @RichelleFlan & @MoroElena4 - Speaking to the MEP - #women #parkinsons @womenspdproject
https://t.co/uJBMbyXB0t